Study at v1.0.0
NCT00095719
8c8876e53b6f3cd96c15a751b599767bcf25c459541d0e78b4ee942984809366 · where else it appears
Data
{
"briefSummary": "The purpose of this trial is to test the safety \\& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.",
"completionDate": "2005-03",
"conditions": [
"Dementia",
"Alzheimer's Disease"
],
"enrollmentCount": 125,
"enrollmentType": null,
"nctId": "NCT00095719",
"phase": "PHASE3",
"sponsorId": "otsuka-pharmaceutical-development-commercialization-inc",
"startDate": "2003-12",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "A Safety & Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia",
"url": "https://clinicaltrials.gov/study/NCT00095719"
}History in this collection
- addedv1.0.0Jun 12, 2026this version